Cindy Jacobs
2022
In 2022, Cindy Jacobs earned a total compensation of $1.1M as President and Chief Medical Officer at OncoGenex Pharmaceuticals, a 5% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $159,250 |
|---|---|
| Option Awards | $233,135 |
| Salary | $455,000 |
| Stock Awards | $268,450 |
| Total | $1,115,835 |
Jacobs received $455K in salary, accounting for 41% of the total pay in 2022.
Jacobs also received $159.3K in non-equity incentive plan, $233.1K in option awards and $268.5K in stock awards.
Rankings
In 2022, Cindy Jacobs' compensation ranked 2,819th out of 5,760 executives tracked by ExecPay. In other words, Jacobs earned more than 51.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,819 out of 5,760 | 51st |
Division Manufacturing | 1,572 out of 3,136 | 50th |
Major group Chemicals And Allied Products | 730 out of 1,422 | 49th |
Industry group Drugs | 682 out of 1,323 | 49th |
Industry In Vitro and In Vivo Diagnostic Substances | 13 out of 29 | 55th |
Source: SEC filing on April 28, 2023.
Jacobs' colleagues
We found two more compensation records of executives who worked with Cindy Jacobs at OncoGenex Pharmaceuticals in 2022.
News
OncoGenex Pharmaceuticals CEO John Bencich's 2022 pay slips 7% to $1.5M
April 28, 2023
OncoGenex Pharmaceuticals CEO John Bencich's 2021 pay jumps 82% to $1.6M
April 21, 2022
OncoGenex Pharmaceuticals CEO Richard Stewart's 2020 pay jumps 30% to $1M
March 30, 2021
OncoGenex Pharmaceuticals CEO Richard Stewart's 2019 pay falls 27% to $797K
April 2, 2020
OncoGenex Pharmaceuticals CEO Richard Stewart's 2018 pay jumps 423% to $1.1M
March 28, 2019